AstraZeneca
Names Davis Vp, Corporate Communications
AstraZeneca announced the appointment of Lisa R. Davis
to the position of Vice President, Corporate Communications. In her new
position, Davis will be based in AstraZeneca’s U.S. headquarters in
Wilmington, Del., and will be responsible for overseeing all internal and
external corporate communications on behalf of AstraZeneca in the U.S.
“With a
history of discovering and developing some of the world's leading
pharmaceutical products, AstraZeneca is committed to helping patients have
access to the medicines and care they need to live longer, healthier lives,"
said Tony Zook, President and CEO, AstraZeneca U.S. Today, the company
is even more committed to making patient health a priority and to
communicating effectively to people about how to stay healthy.
AstraZeneca
realizes the need to find different ways to reach people, as well as develop
channels for them to communicate back, and hear what they have to say, noted
David Nicoli, Vice President, Corporate Affairs for AstraZeneca U.S.
"Lisa is a
top-notch communications professional and her diverse experiences coupled with
her strategic leadership skills, are essential to AstraZeneca's communications
efforts and a valuable asset to the Company,” he said.
Davis most
recently served as the head of Public Relations and Communications for AARP,
the nation’s largest organization for people aged 50+. Prior to joining AARP,
she was the National Deputy Press Secretary for the Clinton/Gore ’96
Re-election Campaign. From 1993-1996, Davis served as the Press Secretary for
the Democratic Leadership Council and its associated think tank, the
Progressive Policy Institute, where she was responsible for all public
relations activities. Davis holds Masters Degrees in Business Administration
and in Public Administration from Howard University, Washington, DC, and a
Bachelor of Arts degree in Communications Studies from the University of North
Carolina at Greensboro. Davis was also recently a Fellow at Harvard
University’s Institute of Politics.
AstraZeneca (www.astrazeneca-us.com)
is a major international healthcare business engaged in the research,
development, manufacture and marketing of prescription pharmaceuticals and the
supply of healthcare services. It is one of the world's leading
pharmaceutical companies with healthcare sales of $23.95 billion and leading
positions in sales of gastrointestinal, cardiovascular, neuroscience,
respiratory, oncology and infection products. In the United States,
AstraZeneca is a $10.77 billion healthcare business with more than 12,000
employees. AstraZeneca is listed in the Dow Jones Sustainability Index
(Global) as well as the FTSE4Good Index.
